Summary?
GeneID 6449
Symbol SGTA
Synonyms SGT|alphaSGT|hSGT
Description small glutamine rich tetratricopeptide repeat containing alpha
Reference MIM:603419|HGNC:HGNC:10819|Ensembl:ENSG00000104969|HPRD:04568|Vega:OTTHUMG00000180474
Gene type protein-coding
Map location 19p13
Pascal p-value 1.26E-4
Sherlock p-value 0.995
Fetal beta 0.443
DMG 1 (# studies)
eGene Myers' cis & trans

Gene in Data Sources
Gene set name Method of gene set Description Info
CV:PGCnp Genome-wide Association Study GWAS
DMG:Jaffe_2016 Genome-wide DNA methylation analysis This dataset includes 2,104 probes/CpGs associated with SZ patients (n=108) compared to 136 controls at Bonferroni-adjusted P < 0.05. 1

Section I. Genetics and epigenetics annotation

@Differentially methylated gene

Probe Chromosome Position Nearest gene P (dis) Beta (dis) FDR (dis) Study
cg19693284 19 2783607 SGTA 2.01E-8 -0.011 6.99E-6 DMG:Jaffe_2016

@eQTL annotation

SNP ID Chromosome Position eGene Gene Entrez ID pvalue qvalue TSS distance eQTL type
rs7670908 chr4 110892624 SGTA 6449 0.09 trans
rs9991367 chr4 110894300 SGTA 6449 0.09 trans
rs1578978 chr8 118196802 SGTA 6449 0.09 trans

Section II. Transcriptome annotation

General gene expression (GTEx)

Not available

Gene expression during devlopment (BrainCloud)

Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.

Gene expression of temporal and spatial changes (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 - 26 postconception周),ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.

No co-expressed genes in brain regions


Section IV. Protein-protein interaction annotation

Interactors Aliases B Official full name B Experimental Source PubMed ID
C1QTNF1 CTRP1 | FLJ90694 | GIP | ZSIG37 C1q and tumor necrosis factor related protein 1 Two-hybrid BioGRID 16189514
EFEMP1 DHRD | DRAD | FBLN3 | FBNL | FLJ35535 | MGC111353 | MLVT | MTLV | S1-5 EGF-containing fibulin-like extracellular matrix protein 1 Two-hybrid BioGRID 16189514
EFEMP2 FBLN4 | MBP1 | UPH1 EGF-containing fibulin-like extracellular matrix protein 2 Two-hybrid BioGRID 16189514
F11R CD321 | JAM | JAM-1 | JAM-A | JAM1 | JAMA | JCAM | KAT | PAM-1 F11 receptor Two-hybrid BioGRID 16189514
GHR GHBP growth hormone receptor - HPRD,BioGRID 12735788
GPX7 CL683 | FLJ14777 | GPX6 | NPGPx glutathione peroxidase 7 Two-hybrid BioGRID 16189514
HSP90AA1 FLJ31884 | HSP86 | HSP89A | HSP90A | HSP90N | HSPC1 | HSPCA | HSPCAL1 | HSPCAL4 | HSPN | Hsp89 | Hsp90 | LAP2 heat shock protein 90kDa alpha (cytosolic), class A member 1 - HPRD,BioGRID 12482202
HSPA4 APG-2 | HS24/P52 | MGC131852 | RY | hsp70 | hsp70RY heat shock 70kDa protein 4 Far Western BioGRID 12482202
IGLC1 IGLC immunoglobulin lambda constant 1 (Mcg marker) Two-hybrid BioGRID 16189514
MSTN GDF8 myostatin hSGT interacts with the amino terminal region of myostatin. BIND 14623262
NME3 DR-nm23 | KIAA0516 | NDPK-C | NDPKC | NM23-H3 | c371H6.2 non-metastatic cells 3, protein expressed in Two-hybrid BioGRID 16189514
PFN2 D3S1319E | PFL profilin 2 Two-hybrid BioGRID 16169070
PTN HARP | HBGF8 | HBNF | NEGF1 pleiotrophin Two-hybrid BioGRID 16169070
SGTA SGT | alphaSGT | hSGT small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha - HPRD 9557704
SPP1 BNSP | BSPI | ETA-1 | MGC110940 | OPN secreted phosphoprotein 1 Two-hybrid BioGRID 16189514
SPPL2A IMP3 | PSL2 signal peptide peptidase-like 2A Two-hybrid BioGRID 16189514
SRGN FLJ12930 | MGC9289 | PPG | PRG | PRG1 serglycin Two-hybrid BioGRID 16189514
SYT4 HsT1192 | KIAA1342 synaptotagmin IV Two-hybrid BioGRID 16189514
ZG16 MGC34820 zymogen granule protein 16 Two-hybrid BioGRID 16189514


Section V. Pathway annotation

Pathway name Pathway size # SZGR 2.0 genes in pathway Info
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP 579 346 All SZGR 2.0 genes in this pathway
DOANE RESPONSE TO ANDROGEN DN 241 146 All SZGR 2.0 genes in this pathway
DARWICHE PAPILLOMA PROGRESSION RISK 74 44 All SZGR 2.0 genes in this pathway
SCHLOSSER MYC AND SERUM RESPONSE SYNERGY 32 22 All SZGR 2.0 genes in this pathway
DARWICHE PAPILLOMA RISK HIGH VS LOW DN 32 21 All SZGR 2.0 genes in this pathway
DAIRKEE TERT TARGETS UP 380 213 All SZGR 2.0 genes in this pathway
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP 479 299 All SZGR 2.0 genes in this pathway
BENPORATH SOX2 TARGETS 734 436 All SZGR 2.0 genes in this pathway
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE UP 157 105 All SZGR 2.0 genes in this pathway
PENG GLUTAMINE DEPRIVATION DN 337 230 All SZGR 2.0 genes in this pathway
BLALOCK ALZHEIMERS DISEASE UP 1691 1088 All SZGR 2.0 genes in this pathway
KIM GASTRIC CANCER CHEMOSENSITIVITY 103 64 All SZGR 2.0 genes in this pathway
CUI TCF21 TARGETS 2 UP 428 266 All SZGR 2.0 genes in this pathway
DOUGLAS BMI1 TARGETS UP 566 371 All SZGR 2.0 genes in this pathway
GRADE COLON CANCER UP 871 505 All SZGR 2.0 genes in this pathway
MOOTHA PGC 420 269 All SZGR 2.0 genes in this pathway